BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

WuXi XDC Achieves GMP Release for Singapore Bioconjugate Manufacturing Site

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...

September 23, 2026 | News

Australia’s VVMF Secures TGA GMP Licence for Viral Vector Manufacturing

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO) advises...

September 18, 2026 | News

Altruist Biologics Supports LongBio Pharma’s LP-003 to NMPA BLA Acceptance in China

Enabled by Altruist's integrated CMC development platform, GMP manufacturing and regulatory service capabilities, LP-003 has successfully advanced from c...

September 17, 2026 | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TAT...

September 16, 2026 | News

Novo Holdings Makes Strategic Investment in China’s Wound Care CDMO ForYou Medical

Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd...

September 14, 2026 | News

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics in Strategic Collaboration

Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, R&D and proce...

September 11, 2026 | News

CordenPharma Invests €80M to Expand Sterile Injectable Manufacturing Capacity in Italy

CordenPharma accelerates sterile injectable CDMO manufacturing expansion with €80 million multi-year investment in new facility and additional as...

September 11, 2026 | News

CelluPro Becomes First Chinese Cell Culture Media Supplier to Secure EXCiPACT GMP Certification

CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certif...

September 09, 2026 | News

WuXi AppTec Raises 2026 Interim Dividend to RMB 1.51 Billion Amid Global CRDMO Expansion

WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organizati...

September 01, 2026 | News

Samsung Biologics to Raise KRW 3 Trillion to Fund PolyPeptide Acquisition and Manufacturing Expansion

Samsung Biologics announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensiona...

August 31, 2026 | News

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins

Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities The partnership unites global clinic...

August 31, 2026 | News

Piramal Pharma Acquires Majority Stake in Yapan Bio to Strengthen Biologics CDMO Capabilities

Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics....

August 20, 2026 | News

Merck Expands Singapore BioReliance Lab with First Cell Line Characterisation and GMP NGS Capabilities in Asia Pacific

Expansion adds first BioReliance® Cell Line Characterization and GMP Next-Generation Sequencing in Asia Pacific Enhanced testing capabilities t...

August 12, 2026 | News

Porton Advanced Secures China Commercial Manufacturing Licence for Cell and Gene Therapy CDMO Services

Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Admi...

August 07, 2026 | News

Stay Connected